Le Bastard Quentin, Jenvrin Joel, Gaultier Aurélie, Montassier Emmanuel
Department of Emergency Medicine, CHU Nantes, Nantes Université, Nantes, France.
Cibles Et Médicaments Des Infections Et de L'immunité, Université, IICiMed, Nantes, Nantes, France.
Trials. 2025 Sep 1;26(1):327. doi: 10.1186/s13063-025-09046-8.
Prehospital airway management is a critical and high-risk procedure in emergency medicine. First-pass intubation success is essential to reduce complications such as hypoxemia, aspiration, and hemodynamic instability. Although the bougie is commonly used in inhospital settings for difficult intubations, its routine use in first-attempt prehospital intubation in patients without difficult airway predictors has not been evaluated in randomized controlled trials.
The BETA study is a multicenter, randomized, controlled, single-blinded superiority trial comparing bougie-assisted intubation with standard endotracheal tube intubation in adult patients (≥ 18 years) requiring prehospital intubation without predictors of difficult airway. A total of 710 participants will be randomized (1:1) across 10 French mobile intensive care units (MICUs). The primary outcome is first-attempt intubation success. Secondary outcomes include adverse events, glottic view, procedure duration, desaturation, perceived difficulty, and airway injuries. Data will be analyzed using logistic regression with a mixed model.
This trial will be the first to assess whether the routine use of a bougie improves first-attempt intubation success in prehospital settings. If successful, the intervention could shape future airway management practices.
ClinicalTrials.gov NCT06307392. Registered on March 26, 2024.
院前气道管理是急诊医学中一项关键且高风险的操作。首次插管成功对于减少诸如低氧血症、误吸和血流动力学不稳定等并发症至关重要。尽管探条在医院环境中常用于困难插管,但在没有困难气道预测因素的患者首次院前插管中常规使用探条尚未在随机对照试验中进行评估。
BETA研究是一项多中心、随机、对照、单盲优效性试验,比较在需要院前插管且无困难气道预测因素的成年患者(≥18岁)中,探条辅助插管与标准气管内导管插管的效果。共有710名参与者将在法国的10个移动重症监护单元(MICU)中按1:1随机分组。主要结局是首次插管成功。次要结局包括不良事件、声门视野、操作持续时间、血氧饱和度下降、感知难度和气道损伤。数据将使用混合模型的逻辑回归进行分析。
这项试验将首次评估在院前环境中常规使用探条是否能提高首次插管成功率。如果成功,该干预措施可能会塑造未来的气道管理实践。
ClinicalTrials.gov NCT06307392。于2024年3月26日注册。